Rafa Laboratories is a pharmaceutical company that markets, manufactures, and distributes consumer health products and prescription and over-the-counter medicines, mainly proprietary formulations as well as generic formulations.
The company manufactures a wide variety of medications based on in-house development and through external agreements. Rafa Laboratories is also involved in marketing drugs produced by international corporations such as Dr. Falk Pharma, Helsinn Healthcare, Boehringer Ingelheim, Purdue Pharma, 3M Healthcare, United Therapeutics, and Mundipharma.
Rafa Laboratories received FDA approval for their 10 mg midazolam autoinjector, which can treat seizures caused by nerve agent exposure.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Rafa Laboratories Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
May 20, 2026
en.globes.co.il
The pharmaceutical company, controlled by FIMI, is one of the oldest in the Israeli economy.
null
Nov 19, 2025
www.prnewswire.com
/PRNewswire/ -- Rafa Laboratories, a global leader in Chemical, Biological, Radiological, and Nuclear hazards medical countermeasures and Biodefense, today...
#Product Stage #Partners
Jun 23, 2024
www.themarker.com
שווי של 1.2 מיליארד שקל: פימי במגעים למכירת 10%–15% מרפא
#Investment
Aug 29, 2022
www.prnewswire.com
Rafa Receives FDA Approval For Life-saving Midazolam Autoinjector
#Partners #Customers
Aug 1, 2022
www.prnewswire.com
Rafa Laboratories to acquire a significant stake in ExCEEd Orphan and expand its international capabilities in medicines addressing rare diseases
The pharmaceutical company, controlled by FIMI, is one of the oldest in the Israeli economy.
null
Nov 19, 2025
www.prnewswire.com
/PRNewswire/ -- Rafa Laboratories, a global leader in Chemical, Biological, Radiological, and Nuclear hazards medical countermeasures and Biodefense, today...
#Product Stage #Partners
Jun 23, 2024
www.themarker.com
שווי של 1.2 מיליארד שקל: פימי במגעים למכירת 10%–15% מרפא
#Investment
Aug 29, 2022
www.prnewswire.com
Rafa Receives FDA Approval For Life-saving Midazolam Autoinjector
#Partners #Customers
Aug 1, 2022
www.prnewswire.com
Rafa Laboratories to acquire a significant stake in ExCEEd Orphan and expand its international capabilities in medicines addressing rare diseases